{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:21:08Z","timestamp":1768346468839,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2012,10,1]]},"DOI":"10.1038\/jhh.2011.80","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T09:27:45Z","timestamp":1314869265000},"page":"577-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study"],"prefix":"10.1038","volume":"26","author":[{"given":"A I","family":"Kanaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P A","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P I","family":"Georgianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P C","family":"Stafylas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Kanavos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I M","family":"Tziolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A N","family":"Lasaridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,1]]},"reference":[{"key":"BFjhh201180_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227\u2013239.","journal-title":"Circulation"},{"key":"BFjhh201180_CR2","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495\u20131504.","journal-title":"N Engl J Med"},{"key":"BFjhh201180_CR3","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","volume":"279","author":"JR Downs","year":"1998","unstructured":"Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615\u20131622.","journal-title":"JAMA"},{"key":"BFjhh201180_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/MJT.0b013e31819cdc86","volume":"17","author":"C Palaniswamy","year":"2010","unstructured":"Palaniswamy C, Selvaraj DR, Selvaraj T, Sukhija R . Mechanisms underlying pleiotropic effects of statins. Am J Ther 2010; 17: 75\u201378.","journal-title":"Am J Ther"},{"key":"BFjhh201180_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/157016107780368307","volume":"5","author":"PA Sarafidis","year":"2007","unstructured":"Sarafidis PA, Kanaki AI, Lasaridis AN . Effects of statins on blood pressure: a review of the experimental and clinical evidence. Curr Vasc Pharmacol 2007; 5: 155\u2013161.","journal-title":"Curr Vasc Pharmacol"},{"key":"BFjhh201180_CR6","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1161\/hq1201.099430","volume":"21","author":"T Ichiki","year":"2001","unstructured":"Ichiki T, Takeda K, Tokunou T, Iino N, Egashira K, Shimokawa H et al. Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells. ArteriosclerThromb Vasc Biol 2001; 21: 1896\u20131901.","journal-title":"ArteriosclerThromb Vasc Biol"},{"key":"BFjhh201180_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/01.HYP.30.4.968","volume":"30","author":"J Jiang","year":"1997","unstructured":"Jiang J, Roman RJ . Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension 1997; 30: 968\u2013974.","journal-title":"Hypertension"},{"key":"BFjhh201180_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1586\/erc.10.59","volume":"8","author":"V Correa Jr","year":"2010","unstructured":"Correa Jr V, Gus M, Fuchs FD . Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects? Expert Rev Cardiovasc Ther 2010; 8: 775\u2013779.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"BFjhh201180_CR9","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1185\/03007990903098081","volume":"25","author":"M Stepien","year":"2009","unstructured":"Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J . Role and significance of statins in the treatment of hypertensive patients. Curr Med Res Opin 2009; 25: 1995\u20132005.","journal-title":"Curr Med Res Opin"},{"key":"BFjhh201180_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.jhh.1001470","volume":"16","author":"J Raison","year":"2002","unstructured":"Raison J, Rudnichi A, Safar ME . Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. J Hum Hypertens 2002; 16: 705\u2013710.","journal-title":"J Hum Hypertens"},{"key":"BFjhh201180_CR11","first-page":"3","volume":"33","author":"G Sartor","year":"1995","unstructured":"Sartor G, Katzman P, Eizyk E, Kalen J, Nilsson A, Ugander L et al. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus. Int J Clin Pharmacol Ther 1995; 33: 3\u20136.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"BFjhh201180_CR12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0895-7061(97)00050-2","volume":"10","author":"BH Sung","year":"1997","unstructured":"Sung BH, Izzo JL, Wilson MF . Effects of cholesterol reduction on BP response to mental stress in patients with high cholesterol. Am J Hypertens 1997; 10: 592\u2013599.","journal-title":"Am J Hypertens"},{"key":"BFjhh201180_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/01.hjh.0000163132.84890.c4","volume":"23","author":"E O'Brien","year":"2005","unstructured":"O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23: 697\u2013701.","journal-title":"J Hypertens"},{"key":"BFjhh201180_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/01.HYP.0000259737.43916.42","volume":"49","author":"P Strazzullo","year":"2007","unstructured":"Strazzullo P, Kerry SM, Barbato A, Versiero M, D'Elia L, Cappuccio FP . Do statins reduce blood pressure?: A meta-analysis of randomized, controlled trials. Hypertension 2007; 49: 792\u2013798.","journal-title":"Hypertension"},{"key":"BFjhh201180_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archinte.168.7.721","volume":"168","author":"BA Golomb","year":"2008","unstructured":"Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH . Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med 2008; 168: 721\u2013727.","journal-title":"Arch Intern Med"},{"key":"BFjhh201180_CR16","doi-asserted-by":"publisher","first-page":"c1197","DOI":"10.1136\/bmj.c1197","volume":"340","author":"G Mancia","year":"2010","unstructured":"Mancia G, Parati G, Revera M, Bilo G, Giuliano A, Veglia F et al. Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial. BMJ 2010; 340: c1197.","journal-title":"BMJ"},{"key":"BFjhh201180_CR17","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007; 25: 1751\u20131762.","journal-title":"J Hypertens"},{"key":"BFjhh201180_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/01.HYP.26.5.835","volume":"26","author":"E O'Brien","year":"1995","unstructured":"O'Brien E, Atkins N, Staessen J . State of the market. A review of ambulatory blood pressure monitoring devices. Hypertension 1995; 26: 835\u2013842.","journal-title":"Hypertension"},{"key":"BFjhh201180_CR19","doi-asserted-by":"publisher","first-page":"91S","DOI":"10.1016\/0895-7061(96)87761-2","volume":"9","author":"WB White","year":"1996","unstructured":"White WB . Relevance of the trough-to-peak ratio to the 24\u2009h blood pressure load. Am J Hypertens 1996; 9: 91S\u201396S.","journal-title":"Am J Hypertens"},{"key":"BFjhh201180_CR20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1161\/01.HYP.34.6.1281","volume":"34","author":"N Glorioso","year":"1999","unstructured":"Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 1999; 34: 1281\u20131286.","journal-title":"Hypertension"},{"key":"BFjhh201180_CR21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0895-7061(01)02210-5","volume":"14","author":"E Leibovitz","year":"2001","unstructured":"Leibovitz E, Hazanov N, Zimlichman R, Shargorodsky M, Gavish D . Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. Am J Hypertens 2001; 14: 1096\u20131098.","journal-title":"Am J Hypertens"},{"key":"BFjhh201180_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/01.fjc.0000175432.56789.e6","volume":"46","author":"L Terzoli","year":"2005","unstructured":"Terzoli L, Mircoli L, Raco R, Ferrari AU . Lowering of elevated ambulatory blood pressure by HMG-CoA reductase inhibitors. J Cardiovasc Pharmacol 2005; 46: 310\u2013315.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFjhh201180_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5551\/jat.12.205","volume":"12","author":"K Shinohara","year":"2005","unstructured":"Shinohara K, Shoji T, Kimoto E, Yokoyama H, Fujiwara S, Hatsuda S et al. Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. J Atheroscler Thromb 2005; 12: 205\u2013210.","journal-title":"J Atheroscler Thromb"},{"key":"BFjhh201180_CR24","first-page":"272","volume":"128","author":"G Abetel","year":"1998","unstructured":"Abetel G, Poget PN, Bonnabry JP . Hypotensive effect of an inhibitor of cholesterol synthesis (fluvastatin). A pilot study. Schweiz Med Wochenschr 1998; 128: 272\u2013277.","journal-title":"Schweiz Med Wochenschr"},{"key":"BFjhh201180_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1081\/JDI-56610","volume":"27","author":"M Kanbay","year":"2005","unstructured":"Kanbay M, Yildirir A, Bozbas H, Ulus T, Bilgi M, Muderrisoglu H et al. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Ren Fail 2005; 27: 297\u2013303.","journal-title":"Ren Fail"},{"key":"BFjhh201180_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/08037050903576726","volume":"19","author":"AM Kuklinska","year":"2010","unstructured":"Kuklinska AM, Mroczko B, Musial WJ, Sawicki R, Kozieradzka A, Usowicz-Szarynska M et al. Influence of atorvastatin on blood pressure control in treated hypertensive, normolipemic patients - an open, pilot study. Blood Press 2010; 19: 260\u2013266.","journal-title":"Blood Press"},{"key":"BFjhh201180_CR27","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1253\/circj.CJ-10-0427","volume":"74","author":"ME Gomes","year":"2010","unstructured":"Gomes ME, Tack CJ, Verheugt FW, Smits P, Lenders JW . Sympathoinhibition by atorvastatin in hypertensive patients. Circ J 2010; 74: 2622\u20132626.","journal-title":"Circ J"},{"key":"BFjhh201180_CR28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","volume":"97","author":"U Laufs","year":"1998","unstructured":"Laufs U, La F, Plutzky J, Liao JK . Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129\u20131135.","journal-title":"Circulation"},{"key":"BFjhh201180_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1034\/j.1600-0773.2003.930304.x","volume":"93","author":"A Bergdahl","year":"2003","unstructured":"Bergdahl A, Persson E, Hellstrand P, Sward K . Lovastatin induces relaxation and inhibits L-type Ca(2+) current in the rat basilar artery. Pharmacol Toxicol 2003; 93: 128\u2013134.","journal-title":"Pharmacol Toxicol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201180","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T14:50:12Z","timestamp":1647528612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10,1]]}},"alternative-id":["BFjhh201180"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2011.80","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,1]]},"assertion":[{"value":"26 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}